United Neuroscience’s Alzheimer’s vaccine candidate UB-311 was found safe and well-tolerated, triggering an antibody response against beta-amyloid in most of the patients, according to Phase 2a trial results.

https://alzheimersnewstoday.com/…/ub-311-safe-effective-ph…/